Fig. 4From: Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleedingHHT patients on iron therapy have increased ESS. Removing patients with history of GI bleeding, HHT patients not on iron therapy (n = 52) had a significantly lower ESS compared to HHT patients on iron therapy (n = 83). Iron therapy includes oral iron, IV iron or regular red blood cell transfusions. Values are median ± 5–95% interval, p-value determined by student’s t-testBack to article page